Boston Scientific (BSX) Return on Capital Employed (2009 - 2026)

Boston Scientific has disclosed Return on Capital Employed across 18 years of filings, most recently posting 9.62% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 9.62%, up 141.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 9.62% (up 141.0% YoY), and the FY2025 annual result was 10.01%, up 158.0% from the prior year.
• Return on Capital Employed came in at 9.62% for Q1 2026 at Boston Scientific, roughly flat from 9.57% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 9.62% in Q1 2026 to a low of 4.62% in Q1 2022.
• The 5-year median for Return on Capital Employed is 7.9% (2023), against an average of 7.4%.
• Across the five-year window, Return on Capital Employed jumped 410 bps in 2022 and grew 15 bps in 2024, its largest moves.
• Boston Scientific's Return on Capital Employed stood at 5.81% in 2022, then soared by 36 bps to 7.9% in 2023, then increased by 2 bps to 8.05% in 2024, then advanced by 19 bps to 9.57% in 2025, then gained by 0 bps to 9.62% in 2026.
• The last three Return on Capital Employed figures came in at 9.62% (Q1 2026), 9.57% (Q4 2025), and 9.41% (Q3 2025), per Business Quant data.